Cancer-associated thrombosis (including venous thromboembolism (VTE) and arterial
events) is highly consequential for patients with cancer and is associated with worsened …

Cells release membrane enclosed nano-sized vesicles termed extracellular vesicles (EVs)
that function as mediators of intercellular communication by transferring biological …

Thromboembolism in people with cancer still remains a major health problem and is a
leading cause of mortality after cancer itself, despite being a largely preventable disease. 1 …

Curcuma longa is very well-known medicinal plant not only in the Asian hemisphere but also
known across the globe for its therapeutic and medicinal benefits. The active moiety of …

Objectives Tofacitinib is a Janus kinase inhibitor for the treatment of rheumatoid arthritis
(RA), psoriatic arthritis (PsA) and ulcerative colitis, and has been investigated in psoriasis …

Podoplanin is a small cell-surface mucin-like glycoprotein that plays a crucial role in the
development of the alveoli, heart, and lymphatic vascular system. Emerging evidence …

Patients with cancer have an increased risk of both arterial and venous thrombotic events
compared with the general population. Both the site and stage of cancer are known to …

The application of chimeric antigen receptor (CAR) T-cell therapy as a tumor immunotherapy
has received great interest in recent years. This therapeutic approach has been used to treat …

Extracellular vesicles (EVs) are well-established mediators of cell-to-cell communication.
EVs can be released by every cell type and they can be classified into three major groups …

Most patients are at high risk of thrombosis during cancer treatment. However, the major
discrepancy in the therapeutic mechanisms and microenvironment between tumors and …